https://www.avient.com/sites/default/files/2021-04/additives-listing.pdf
Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/2025-01/Maxxam NHFR Non-Halogen Flame Retardant Polyolefins - Product Selector Guide EMEA.pdf
We also provide options for custom
formulations using recycled polypropylene (PP) and
polyethylene (PE).
1.844.4AVIENT
www.avient.com
Copyright © 2025, Avient Corporation.
https://www.avient.com/sites/default/files/2025-01/Firearms Product Selection Guide.pdf
PRODUCT SELECTION GUIDE
AESTHETIC APPEAL
Custom Colors, Special Effects, Color Stability
SOLUTION: Custom Polymer Colorants,
Pre-Colored Materials
POSSIBILITIES: Grips, Stocks, Frames,
Magazine Bases
DYNAMIC COMFORT
Shock Absorption, Vibration Damping
SOLUTION: Thermoplastic Elastomers
POSSIBILITIES: Recoil Pads, Straps
TACTILE EXPERIENCE
Soft Touch, Wet Grip
SOLUTION: Thermoplastic
Elastomers
POSSIBILITIES: Grips,
Slides, Triggers
PERFORMANCE & FUNCTION
Custom Weight, Toughness,
Reduced Machining, Metal Replacement,
Thermal Management and Stability,
Wear Resistance
SOLUTION: Structural Reinforced
Formulations, Super Tough Formulations,
Composite Heat Release Technology,
High-Density Modified Formulations,
Internally Lubricated Formulations
POSSIBILITIES: Stocks,
Frames, Barrels
1.844.4AVIENT
www.avient.com
Copyright © 2024, Avient Corporation.
https://www.avient.com/sites/default/files/2024-11/Dispersions Healthcare Industry Bulletin.pdf
AESTHETIC APPEAL AND VERSATILITY
Custom colors, special effects, functional
additives
CONSISTENT QUALITY
Lot-to-lot consistency, tight color tolerances,
reproducible dispersions
DESIGN AND PROCESSING
Application development support and
technical service
REGULATORY COMPLIANCE
Product stewardship expertise and
regulatory support
SURFACE PROTECTION
Lightfastness, chemical resistance, durability
ENHANCED PERFORMANCE
Electrical conductivity, mechanical
property retention
1.844.4AVIENT
www.avient.com
Copyright © 2024, Avient Corporation.
https://www.avient.com/sites/default/files/2023-07/AVNT Q2 2023 Earnings Presentation%5B70%5D.pdf
AVIENT CORPORATION
S E C O N D Q U A R T E R 2 0 2 3 R E S U L T S
(NYSE: AVNT)
J U LY 2 7 , 2 0 2 3
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years.
24
EV / 2023E EBITDA
Historic Multiple
6.5
8.3
10.3
14.4
13.6 13.6
12.4
9.0
20.2
18.2
11.5
10.6
9.7 9.6
8.7 8.3
01
1)
01
8)
02
3)
Avient Specialty
Other Specialty /
SEGMENT DATA
U.S. & Canada
40%
37%
18%
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
20%
24%
Building and
END MARKET REVENUE
$2,355M $402M
$1,300M $272M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$592M$3,653M
(1)
9%
26
(1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs
2022 REVENUE | $2 .4 B ILL ION
34%
38%
20%
END MARKET REGION
27
34%
21%
Building &
1% Energy
2%
COLOR, ADDITIVES & INKS
2022 PRO FORMA REVENUE | $1 .3 B ILL ION
52%
35%
28
19%
8%Industrial
16%
9% Defense
Building &
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
32%
27%
14%
Building &
3%
1% Defense
1%
(18% of sales)
9%
2022 PROFORMA AVIENT REGIONAL SALES
27%
14%
17%
Building &
(37% of sales)Transportation
24%
12%
Building &
US &
Canada
(40% of sales)
7%
56%
23%
7%
Building &
1%
LATAM
(5% of sales)
3%
29
BY END MARKET
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/resources/Universal_Polyamide_Overmold_Thermoplastic_Elastomer.pdf
Universal Polyamide Overmold Thermoplastic Elastomer
Krishna Venkataswamy and Jiren Gu
GLS Corporation, 833 Ridgeview Drive, McHenry, IL 60050
ABSTRACT
Overmolding of thermoplastic elastomers (TPEs) for consumer applications has been driven by the escalating
market trends in enhanced ergonomic feel, touch, grippability, aesthetics and cushioning against impact,
vibration isolation and insulation.
Page 11 of 11
GLS Corporation, 833 Ridgeview Drive, McHenry, IL 60050
NYLON MOLDING PROCESS
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_ES-SPAIN2.pdf
Lea nuestra Política global de gastos
empresariales disponible en The Loop, en People & Departments
(Personas y departamentos), Ethics & Corporate Policies (Ética y
políticas corporativas).
Puede encontrarlo en The Loop, en
People & Departments (Personas y departamentos), Ethics
& Corporate Policies (Ética y políticas corporativas).
La
Política de regalos y entretenimiento de Avient está disponible en The
Loop, en People & Departments (Personas y departamentos), Ethics &
Corporate Policies (Ética y Políticas corporativas).
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_ZH-TW2.pdf
詳情載
於 The Loop 上的《全球隱私與資料保護政策》,位於「People &
Departments, Ethics & Corporate Policies」。
詳情載於 The Loop 上的《資訊系統使用政策》,位於「People &
Departments, Ethics & Corporate Policies」。
您可以在 The Loop 找到,位於「People & Departments,
Ethics & Corporate Policies」下。
https://www.avient.com/sites/default/files/2022-03/Asia SEM Healthcare Product Selection Guide %281%29.pdf
ST5200-8030
ESD BK001 1 5 27 52 1980 42 E3
ST5200-8035
ESD BK001 1 20 22 37 1460 150 E3
+86.21.60284888
www.avient.com
Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-processing-guide.pdf
Insure proper cushion
For questions or issues, please contact
Specialty Engineered Materials Technical Support at 1.844.4AVIENT
www.avient.com
Copyright © 2020, Avient Corporation.